Sign in

CIK 0001622229

  • Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465308248
Phone
+1 617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,689,493
in 1 filing, $1.7M under 10b5-1 plans

Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Morris Arlene −$1.7M Director sold 100% of stake

Reading 18 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-31 Fairmount Funds Management LLC Director Conversion +7,000,000 12,503,418
2026-03-31 Fairmount Funds Management LLC Director Sale −7,000,000 $34.66 $242.6M 5,503,418
2026-03-31 Fairmount Funds Management LLC Director Conversion · Series A Convertible Preferred Stock −28,000 39,414
2026-01-22 Fairmount Funds Management LLC Director Sale −3,500,000 $36.40 $127.4M 5,503,418
2025-07-10 Fairmount Funds Management LLC Director Purchase +2,777,777 $9.00 $25.0M 9,003,418
2024-06-10 Fairmount Funds Management LLC Director Option exercise +1,500,000 6,225,641
2024-06-10 Fairmount Funds Management LLC Director Option exercise · Series B Convertible Preferred Stock −1,500 0
2024-03-28 Fairmount Funds Management LLC Director Other disposition −286,851 0
2024-03-28 Fairmount Funds Management LLC Director Other acquisition +286,851 4,725,641
2024-03-28 Fairmount Funds Management LLC Director Other disposition · Series A Convertible Preferred Stock −11,914 0
2024-03-28 Fairmount Funds Management LLC Director Other acquisition · Series A Convertible Preferred Stock +11,914 67,414
2024-02-16 Fairmount Funds Management LLC 10% owner Grant or award +1,166,666 $7.50 $8.7M 4,438,790
2024-02-16 Fairmount Funds Management LLC 10% owner Grant or award · Series B Convertible Preferred Stock +1,500 $7,500.00 $11.3M 1,500
2023-06-09 Fairmount Funds Management LLC 10% owner Purchase +800,000 $12.00 $9.6M 3,272,124
2022-06-16 Fairmount Funds Management LLC 10% owner Purchase +1,200,000 $8.25 $9.9M 2,472,124
2020-07-09 Fairmount Funds Management LLC 10% owner Purchase · Series A Convertible Preferred Stock +3,692 $880.00 $3.2M 11,914
2020-07-09 Fairmount Funds Management LLC 10% owner Purchase · Series A Convertible Preferred Stock +19,035 $880.00 $16.8M 55,500
2020-07-06 Fairmount Funds Management LLC 10% owner Other acquisition +1,147,406 1,147,406
2020-07-06 Fairmount Funds Management LLC 10% owner Other acquisition +5,088,497 5,088,497
2020-07-06 Fairmount Funds Management LLC 10% owner Other acquisition · Series A Convertible Preferred Stock +8,222 8,222

Page 1 of 2 · 21 trades